Weight and breast cancer drugs: does size matter?
NCT ID NCT02095184
First seen Apr 17, 2026 · Last updated Jun 14, 2026 · Updated 10 times
Summary
This study looked at whether postmenopausal women with higher body fat respond differently to standard doses of aromatase inhibitors (anastrozole or letrozole) compared to women with lower body fat. The goal was to see if weight affects how well these hormone-blocking pills shrink breast tumors before surgery. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Maryland Greenebaum Cancer Center
Baltimore, Maryland, 21201, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.